Home

RenovoRx, Inc. - Common Stock (RNXT)

0.9748
+0.0248 (2.61%)

Renovorx Inc is a biotechnology company focused on developing innovative therapeutics designed to address unmet needs in the field of chronic diseases

The company specializes in the creation of targeted treatment delivery systems, with an emphasis on utilizing proprietary technologies to improve the efficacy and safety of existing therapies. By harnessing advanced drug formulations and delivery mechanisms, Renovorx aims to enhance patient outcomes and quality of life through personalized medicine strategies. Their commitment to research and development positions them at the forefront of modern biomedical advancements, working to bring transformative solutions to patients suffering from complex health conditions.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is RenovoRx, Inc. - Common Stock publicly traded?
Yes, RenovoRx, Inc. - Common Stock is publicly traded.
What exchange does RenovoRx, Inc. - Common Stock trade on?
RenovoRx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RenovoRx, Inc. - Common Stock?
The ticker symbol for RenovoRx, Inc. - Common Stock is RNXT on the Nasdaq Stock Market
What is the current price of RenovoRx, Inc. - Common Stock?
The current price of RenovoRx, Inc. - Common Stock is 0.9748
When was RenovoRx, Inc. - Common Stock last traded?
The last trade of RenovoRx, Inc. - Common Stock was at 3:59 pm EST on March 6th, 2025